ROYAL BANK OF CANADA - SUMMIT THERAPEUTICS PLC ownership

SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 14 filers reported holding SUMMIT THERAPEUTICS PLC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SUMMIT THERAPEUTICS PLC
ValueSharesWeighting
Q3 2018$24,000
-17.2%
11,000
-7.6%
0.00%
Q2 2018$29,000
-81.2%
11,9000.0%0.00%
Q1 2018$154,000
+450.0%
11,900
+376.0%
0.00%
Q4 2017$28,000
-9.7%
2,5000.0%0.00%
Q3 2017$31,000
+10.7%
2,5000.0%0.00%
Q2 2017$28,0002,5000.00%
Other shareholders
SUMMIT THERAPEUTICS PLC shareholders Q2 2017
NameSharesValueWeighting ↓
Worth Asset Management, LLC 10,956$20,4880.02%
Lindbrook Capital, LLC 782$1,4620.00%
View complete list of SUMMIT THERAPEUTICS PLC shareholders